JAK2 and myeloproliferative neoplasm: Single-colony sequencing of hematopoietic cells from JAK2-mutant MPN patients and phylogenetic reconstruction revealed that JAK2 and DNMT3A mutations may be acquired in utero in some patients, persisting in early hematopoietic stem/progenitor cells without terminal differentiation [66].